Pharma & Bio
Lifestyle
“Zero Deaths in Four Years—How Was That Possible?”… 10 Questions for the Clinical Trial Lead at BigenCell’s VT-EBV-N Program
“The role of VT-EBV-N is to ensure that treated patients do not have to return to the hospital and to help them achieve a near-complete recovery.”Jeon Young-woo, a professor in the Department of Hemat…
Technology
Ki Min-hyo, CEO of Medici Bio: “Targeting the Next-Generation Gene Therapy Market with a Domestically Developed LNP Platform”
Ki Min-hyo, CEO of Medici Bio. (Photo courtesy of Medici Bio)
“While antibody therapies have driven the growth of the pharmaceutical and biotech industries in the past, I believe gene therapies wi…
Technology
The Survival Strategy for ‘Biotech Penny Stocks’ Frozen Even in the Height of Summer
Graphic: ChatGPT
Low-priced pharmaceutical and biotech stocks are collectively taking steps to defend their share prices in the securities market. This is because, starting this month, so-called “…
Manufacturing
“From Lituo to Estefil and Belpien”… Humedix Co., Ltd. Aims for a Quantum Leap in Earnings Led by Its “Aesthetic Trio”
#Huons Global Co., Ltd. subsidiary Humedix Co., Ltd.(200670)is expanding its aesthetic business portfolio. Humedix Co., Ltd. has been diversifying its revenue streams by expanding its business portfol…
Technology
PharmaResearch, Equipped with U.S.-Based CG USA, Accelerates Expansion into the U.S. ... What Is the Strategy for Reaching 1 Trillion Won in Sales?
PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …
Lifestyle
Yuri Kwon, CEO of Raphas Co., Ltd.: “Microneedles Recognized as a Global Standard Production Platform”
The proprietary platform technologies of domestic biotech ventures have been selected one after another by Japan’s top-tier global manufacturing companies, which are known for their conservatism. The …
Technology
HLB Hits Limit-Up on FDA Optimism; Curiosis and Peptron Rebound Sharply [K-Bio Pulse]
On July 15, South Korean pharmaceutical and biotech stocks rallied, led by a broad surge in HLB affiliates, while Curiosis and Peptron posted double-digit gains.Investor sentiment was buoyed by renewe…
Technology
Are Biotech Stocks Back in the Spotlight?… HLB INC. Hits Daily Limit Up, Curiosis Inc. and Peptron, Inc. Surge [Bio Market Watch]
On the 15th, in the domestic pharmaceutical and biotech stock market, while shares of the HLB INC.(028300) group all hit their daily price limits, #Curiosis Inc. and Peptron, Inc.(087010)showed strong…
Lifestyle
PenetriumBio Moves Directly to U.S. Phase 2 Clinical Trials... Incorporates a Three-Pronged Strategy to Boost Speed, Approval Rate, and Value
As #PenetriumBio, an innovative new drug development company, unveils its strategy to proceed directly to a U.S. Phase 2 clinical trial for “Penetrium”—its core pipeline candidate for treating intract…
Technology
Genomictree Inc. Kicks Off Commercialization of EarlyTec-B… Aims for the $5 Trillion U.S. Market
Genomictree Inc.(228760)is set to enter a phase of full-scale revenue generation following the approval of a deferral for the evaluation of its new medical technology, the bladder cancer molecular dia…